IDL Diagnostics AB (publ) (STO:IDLDX)
Sweden · Delayed Price · Currency is SEK 0.4890
-0.0010 (-0.20%)
Jun 5, 2026, 5:24 PM CET
IDL Diagnostics AB Market Cap
IDL Diagnostics AB has a market cap or net worth of 112.65 million as of June 5, 2026. Its market cap has decreased by -16.55% in one year.
Market Cap
112.65M
Enterprise Value
88.00M
Revenue
54.54M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
Market Cap Chart
Since May 25, 2011, IDL Diagnostics AB's market cap has increased from 16.78M to 112.65M, an increase of 571.40%. That is a compound annual growth rate of 13.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 112.65M | 38.53% |
| Dec 30, 2025 | 81.32M | -9.49% |
| Dec 30, 2024 | 89.84M | -10.76% |
| Dec 29, 2023 | 100.67M | -29.52% |
| Dec 30, 2022 | 142.82M | 31.17% |
| Dec 30, 2021 | 108.88M | -38.54% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 154.45B |
| Sectra AB | 56.45B |
| Getinge AB | 52.94B |
| Camurus AB | 32.71B |
| Boule Diagnostics AB | 122.32M |
| Simris Group AB (PUBL) | 121.21M |
| Arcoma AB | 120.48M |
| Iconovo AB | 118.77M |